Beta · prototype— This site is under construction: rankings, texts and features change every week.

Splose

Active#7 worldwide · Clinic management

Clinic management

HQAustralia
Last roundSeries A · Feb 2026

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Clinic management · worldwideTop 11#7Edition 0 (beta) · Sep 202610 Mar 2027
Rank historySep 2026 · #7 Clinic managementFirst edition: no movements yet.

Estimated valuation

AI · Clinic management ranking (worldwide)
≈ USD 140MUSD 93–210M · Hundreds of M$ Medium confidence
Anchor
Last known equity round: Series A · AUD 46M · Feb 2026

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestorsSource
Feb 2026Series AAUD 46MEquityAthletic Venturessmartcompany.com.au

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Splose as a PDF, on one of three angles only:

ValuationWhat is Splose worth?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Comparable companies in clinic management

Full clinic management ranking →

Investors in Splose: Athletic Ventures

Sources. smartcompany.com.au · spectrumequity.com

Last updated: Sep 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.